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CLINICAL STUDY OF OFLOXACIN工N COMPLICATED
        Ui，RINARY TRACT INFECTION
’！TN’obuyuki Ai〈AzAwA， iViasaya TsuGAwA， Shunji HAyATA，
 Hiroki SAsal〈i， Toshihiko AsAHi and Kenitsu OKiTA
Fronz疏6 z）ψ副鷹η∫げ乙irology， Kagawa Pr・fectuα1（7entral刀‘，spital
       （Chief： Dr． Z Asahi and K． Okita）
  Ofloxacin （O）一LX）was aclministered at a dosc gf 200 mg， three times daily （600 mg） for 1“
days， to 15 patients suffering from complic－cted urinary tract infection． According to the criteria
for clinical evaluation by the UTI committee， exellent and moderate responses were seen in 54 ．0．tt’
at 5 days evaluation， and in 91％ at 14 days eva1uation． No serious side effects were recognized
and no changes in laboratory examination data were observed． We conclude that OFLX Nvas use－
ful in treatment of urinarv tract infection．
                              （Acta Urol．Jpn． 34： 1279－／282， 1988）
Key worcls： Urinary tract infection， Ofioxacin












        効 果 判 定
 本剤5日間投与後および14日間投与後に，UTI薬
効評価基準1＞およびその補遺2）に従って行った。
 症例の一覧をTable 1に示す（Table l）．
 ＊現：尾道市立市民病院 ＊＊現：岡山大学医学部
＊＊＊現：香川県衛生研究所
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Table 1． Clinical summary of complicated UTI pati．ents （1）
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’ Bstore tTeatmentpmsde ftetrtmt
14deys after treatnent
％であった（Table 5）．
  細菌学的効果は，Serratia spp．9株中7株消失，
P．aerUb・inosa 6里中6株消失を示したのを始めとし
て，合計では22株中19株消失，除菌率は86．4％であっ








  Ofloxacin 1＊，グラム陰性およびグラム陽性の好気
性菌に対し，幅広い抗菌スペクトラムと強い殺菌力を
赤沢，ほか：複雑1生尿路感染症・OflQxacin
Table 2．Overall clinical eMcacy in complicated UTI
（5 days treatment）
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Elirnhated 1 3 2． 6｛46％｝
Decreased
Replaced 1 1 2｛15，5％｝
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Table 3． Bacteriologica！ response to OFLX
         in co皿plicated UTI
         （5 days treatrnent）
Table 4． Strains＊ appearing after OFLX
         treatment in complicated UTI
         （5 days treatment）
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Table 5．Overall clinical efficaeiJ in                    i（14 days treatment）
compl c4ted UTI
               Py閣ria
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Decreasod 1 1 2｛18．2％｝
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rl［iable 6． Bacteriological response to OFLX
     in complicated UTI
     （14 days treatment）


















Totat 22 19t86．4el，） 3
’ Persisted：regardless of bacterial
    counts
Table 7． Strains￥’ appearing after NFLX
     treatment in complicated UTI






































’ Regardless of bacterial counts
1）大越正秋，河村信夫：UTI（尿路感染症）薬効
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